title: trans-4-(Aminomethyl)cyclohexane carboxylic acid methylamide (t-AMCHA methylamide) inhibits the physical interaction between urokinase-type plasminogen activator and stratum corneum, and accelerates the recovery of barrier function.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Katsuta
authors.forename: Yuzo
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Eriko
authors.initials: E
authors.lastname: Kawai
authors.forename: Masaru
authors.initials: M
authors.lastname: Suetsugu
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Kohno
authors.forename: Shinji
authors.initials: S
authors.lastname: Inomata
authors.forename: Kenji
authors.initials: K
authors.lastname: Kitamura
mesh_terms: D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D020127:Recovery of Function / Q000187:drug effects; D012867:Skin / Q000187:drug effects* / Q000378:metabolism*; D014148:Tranexamic Acid / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D014568:Urokinase-Type Plasminogen Activator